MREO insider transactions
Mereo BioPharma Group plc (MREO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MREO
- SEC Form 4 filed by Director Ekblom Anders4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Bender Jeremy4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Pakianathan Deepika4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Jacquet Pierre4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Shames Daniel4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Jenkins Annalisa4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Wyzga Michael S4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Yoskowitz Marc J4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Officer Hughes-Wilson Alexandra4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by General Counsel Sermon Charles4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Fox Christine Ann4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Lewicki John A.4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Scots-Knight Denise4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Yoskowitz Marc J4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Bender Jeremy4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Shames Daniel4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Ekblom Anders4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Pakianathan Deepika4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Wyzga Michael S4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Jenkins Annalisa4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Director Jacquet Pierre4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Lewicki John A.4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Fox Christine Ann4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by General Counsel Sermon Charles4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Officer Hughes-Wilson Alexandra4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Scots-Knight Denise4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Executive Officer Scots-Knight Denise sold $381,423 worth of American Depositary Shares representing Ordinary Shares (88,657 units at $4.30), decreasing direct ownership by 10% to 808,921 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Scientific Officer Lewicki John A. sold $69,477 worth of American Depositary Shares representing Ordinary Shares (16,149 units at $4.30), decreasing direct ownership by 17% to 78,630 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- General Counsel Sermon Charles sold $133,051 worth of American Depositary Shares representing Ordinary Shares (30,926 units at $4.30), decreasing direct ownership by 12% to 219,061 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Financial Officer Fox Christine Ann sold $121,693 worth of American Depositary Shares representing Ordinary Shares (28,286 units at $4.30), decreasing direct ownership by 24% to 89,285 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Officer Hughes-Wilson Alexandra sold $637,203 worth of American Depositary Shares representing Ordinary Shares (148,110 units at $4.30), decreasing direct ownership by 75% to 50,475 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- General Counsel Sermon Charles converted options into 65,600 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 36% to 249,987 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Financial Officer Fox Christine Ann converted options into 60,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 104% to 117,571 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Scientific Officer Lewicki John A. converted options into 46,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 94% to 94,779 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Executive Officer Scots-Knight Denise converted options into 188,060 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 27% to 897,578 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Officer Hughes-Wilson Alexandra exercised 208,333 units of American Depositary Shares representing Ordinary Shares at a strike of $0.99, increasing direct ownership by 603% to 242,881 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Director Pakianathan Deepika exercised 105,244 units of American Depositary Shares representing Ordinary Shares at a strike of $1.44 and sold $466,210 worth of American Depositary Shares representing Ordinary Shares (105,244 units at $4.43) (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- General Counsel Sermon Charles sold $161,678 worth of American Depositary Shares representing Ordinary Shares (46,389 units at $3.49), decreasing direct ownership by 20% to 184,387 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Scientific Officer Lewicki John A. sold $84,427 worth of American Depositary Shares representing Ordinary Shares (24,224 units at $3.49), decreasing direct ownership by 33% to 48,779 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Financial Officer Fox Christine Ann sold $147,876 worth of American Depositary Shares representing Ordinary Shares (42,429 units at $3.49), decreasing direct ownership by 42% to 57,571 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Executive Officer Scots-Knight Denise sold $463,487 worth of American Depositary Shares representing Ordinary Shares (132,985 units at $3.49), decreasing direct ownership by 16% to 709,518 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Officer Hughes-Wilson Alexandra sold $115,369 worth of American Depositary Shares representing Ordinary Shares (33,102 units at $3.49), decreasing direct ownership by 49% to 34,548 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Scientific Officer Lewicki John A. converted options into 69,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 1,724% to 73,003 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Executive Officer Scots-Knight Denise converted options into 282,090 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 50% to 842,503 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- General Counsel Sermon Charles converted options into 98,400 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 74% to 230,776 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Officer Hughes-Wilson Alexandra converted options into 60,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 784% to 67,650 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Chief Financial Officer Fox Christine Ann converted options into 90,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 900% to 100,000 units (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Large owner Rubric Capital Management Lp4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Director Wyzga Michael S was granted 25,050 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Director Bender Jeremy was granted 12,550 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- Amendment: SEC Form 4 filed by Officer Hughes-Wilson Alexandra4/A - Mereo BioPharma Group plc (0001719714) (Issuer)
- Hughes-Wilson Alexandra exercised 168,333 units of American Depositary Shares representing Ordinary Shares at a strike of $1.23, sold $297,788 worth of American Depositary Shares representing Ordinary Shares (100,432 units at $2.97) and covered exercise/tax liability with 67,901 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Jacquet Pierre4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Ekblom Anders4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Pakianathan Deepika4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Wyzga Michael S4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Yoskowitz Marc J4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Bender Jeremy4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Shames Daniel4 - Mereo BioPharma Group plc (0001719714) (Issuer)
- SEC Form 4 filed by Jenkins Annalisa4 - Mereo BioPharma Group plc (0001719714) (Issuer)